obesity drug news today glp-1 september 22 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Weight-Loss Drug Demonstration Begins

Extracellular aggregates of A amyloid protein and phosphorylated tau protein are common pathological deposits in the brains of Alzheimers patients

The calorie intake from the pellets consumed during the experimental days and calorie intake on weekend days were similar, and fully complied with the recommended daily energy requirements of the animals (see section Energy requirements in Supplementary Methods)

This includes depressive disorders (F32-33), anxiety (F40-F48), and various aspects of suicidality

Reducing the Risks For those who choose to purchase compounded semaglutide, there are ways to mitigate your risk

Medicaid spending could see increases of an estimated $15 billion over the next decade, with significant variability by state

The takeaway